https://adrenomed.com/ | Anchor | Skip to content A-TITLE Skip to content |
https://adrenomed.com/ | | Kein Text |
https://adrenomed.com/ | Anchor | About Us |
https://adrenomed.com/ | Anchor | Company Profile |
https://adrenomed.com/ | Anchor | Management |
https://adrenomed.com/ | Anchor | Investors |
https://adrenomed.com/ | Anchor | Contact |
https://adrenomed.com/ | Anchor | Research & Development |
https://adrenomed.com/ | Anchor | Mode of Action |
https://adrenomed.com/ | Anchor | Clinical Development |
/publications/ | | Publications |
https://adrenomed.com/ | Anchor | Vascular Integrity |
https://adrenomed.com/ | Anchor | Sepsis & Septic Shock |
https://adrenomed.com/ | Anchor | Adrenomedullin |
https://adrenomed.com/ | Anchor | News & Events |
https://adrenomed.com/ | Anchor | Press releases |
https://adrenomed.com/ | Anchor | Media coverage |
https://adrenomed.com/ | Anchor | Events |
https://adrenomed.com/ | Anchor | Career |
https://adrenomed.com/ | Anchor Textduplikat | About Us |
https://adrenomed.com/ | Anchor Textduplikat | Company Profile |
https://adrenomed.com/ | Anchor Textduplikat | Management |
https://adrenomed.com/ | Anchor Textduplikat | Investors |
https://adrenomed.com/ | Anchor Textduplikat | Contact |
https://adrenomed.com/ | Anchor Textduplikat | Research & Development |
https://adrenomed.com/ | Anchor Textduplikat | Mode of Action |
https://adrenomed.com/ | Anchor Textduplikat | Clinical Development |
/publications/ | Textduplikat | Publications |
https://adrenomed.com/ | Anchor Textduplikat | Vascular Integrity |
https://adrenomed.com/ | Anchor Textduplikat | Sepsis & Septic Shock |
https://adrenomed.com/ | Anchor Textduplikat | Adrenomedullin |
https://adrenomed.com/ | Anchor Textduplikat | News & Events |
https://adrenomed.com/ | Anchor Textduplikat | Press releases |
https://adrenomed.com/ | Anchor Textduplikat | Media coverage |
https://adrenomed.com/ | Anchor Textduplikat | Events |
https://adrenomed.com/ | Anchor Textduplikat | Career |
/2024-04-10-adrenomed-fda-fast... | | AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock |
/2024-04-10-adrenomed-fda-fast... | | Read More » |
/2024-04-02-in-vivo-adrenomed-... | | Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate |
/2024-04-02-in-vivo-adrenomed-... | Textduplikat | Read More » |
/adrenomed-to-attend-san-franc... | | Adrenomed to attend San Francisco industry and investor conferences |
/adrenomed-to-attend-san-franc... | Textduplikat | Read More » |
https://www.linkedin.com/in/dr... | Neues Fenster Extern Subdomain | Kein Text |
https://www.linkedin.com/in/da... | Neues Fenster Extern Subdomain | Kein Text |
https://www.linkedin.com/in/st... | Neues Fenster Extern Subdomain | Kein Text |
https://adrenomed.com/ | Anchor | vascular integrity |
https://adrenomed.com/ | Anchor | vascular integrity. |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain | Shock, 2018 |
https://icm-experimental.sprin... | Neues Fenster Extern Subdomain | Intens Care Med Exp, 2013 |
https://icm-experimental.sprin... | Neues Fenster Extern Subdomain | Intens Care Med, 2013 |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain Textduplikat | Shock, 2018 |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Crit Care Med, 2020 |
https://ccforum.biomedcentral.... | Neues Fenster Extern Subdomain | Crit Care, 2018 |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain Textduplikat | Shock, 2018 |
https://bio-adm.com/index.php?... | Neues Fenster Extern | sphingotest® bio-ADM® |
https://clinicaltrials.gov/ct2... | Neues Fenster Extern | AdrenOSS-2 |
https://www.nature.com/article... | Neues Fenster Extern Subdomain | following article |
https://bmjopen.bmj.com/conten... | Neues Fenster Extern Subdomain | BMJ Open, 2019 |
http://clinicaltrials.gov/ct2/... | Neues Fenster Extern | Phase Ia |
http://clinicaltrials.gov/ct2/... | Neues Fenster Extern | Ib |
https://bpspubs.onlinelibrary.... | Neues Fenster Extern Subdomain | Br J Clin Pharmacol, 2018 |
/publications/ | | VIEW MORE |
https://pubmed.ncbi.nlm.nih.go... | Neues Fenster Extern Subdomain | Blet et al. Crit Care. 2020;28;24(1):69 |
https://www.sciencedirect.com/... | Extern Subdomain | Geven et al. Toxicol Appl Pharmacol, 2019;369:1-16 |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Geven et al. BMJ Open, 2019;9(2) |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain | Geven et al. Shock, 2018;50(2):132-40 |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Geven and Pickkers, Critical Care, 2018;22:159 |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain | Geven et al. Shock, 2018;50(6):648-54 |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Geven et al. Front Immunol, 2018;9:292 |
https://bpspubs.onlinelibrary.... | Neues Fenster Extern Subdomain | Geven et al. Br J Clin Pharmacol, 2018;84(9):2129-41 |
https://www.mdpi.com/2218-273X... | Neues Fenster Extern Subdomain | Karakas et al. Biomolecules 2020;10:1171 |
https://link.springer.com/arti... | Extern Subdomain | Laterre et al. Intensive Care Med, 2021;47(10) |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Marino et al. Critical Care, 2014;18(1):R34 |
https://ccforum.biomedcentral.... | Neues Fenster Extern Subdomain | Mebazza et al. Critical Care, 2018;22(1):354 |
https://www.ncbi.nlm.nih.gov/p... | Neues Fenster Extern Subdomain | Mebazaa et al. J Intensive Care, 2016;4:24 |
https://ccforum.biomedcentral.... | Neues Fenster Extern Subdomain | Mebazaa et al. J Critical Care, 2018;22:354 |
https://icm-experimental.sprin... | Neues Fenster Extern Subdomain | Struck et al. Intensive Care Med Exp, 2013;1:22 |
https://journals.lww.com/shock... | Neues Fenster Extern Subdomain | Thiele et al. Shock, 2020;10.1097/SHK.0000000000001587 |
https://icm-experimental.sprin... | Neues Fenster Extern Subdomain | Wagner et al. Intens Care Med, 2013;1:21 |
https://f1000.com/prime/ext/72... | Neues Fenster Extern | Zink et al. Shock, 2015;44(2):15-6 |
https://www.healthcapital.de/t... | Neues Fenster Extern Subdomain | Sepsis bekämpfen – Leben retten |
https://jamanetwork.com/journa... | Extern | JAMA, 2014 |
https://www.ncbi.nlm.nih.gov/p... | Extern Subdomain | Crit Care Med, 2018 |
https://pubmed.ncbi.nlm.nih.go... | Extern Subdomain | JAMA, 2016 |
/2024-04-10-adrenomed-fda-fast... | Textduplikat | AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock |
/2024-04-10-adrenomed-fda-fast... | Textduplikat | Read More » |
/adrenomed-to-attend-san-franc... | Textduplikat | Adrenomed to attend San Francisco industry and investor conferences |
/adrenomed-to-attend-san-franc... | Textduplikat | Read More » |
/adrenomed-presents-new-findin... | | Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update |
/adrenomed-presents-new-findin... | Textduplikat | Read More » |
/index.php?cat=5 | | More News |
/2024-04-02-in-vivo-adrenomed-... | Textduplikat | Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate |
/2024-04-02-in-vivo-adrenomed-... | Textduplikat | Read More » |
/article-in-mednous-adrenomed-... | | Article in MedNous: Adrenomed prepares global study in septic shock |
/article-in-mednous-adrenomed-... | Textduplikat | Read More » |
/article-on-labiotech-watch-ad... | | Article on LaBiotech: Watch: Adrenomed tackling huge issue of sepsis |
/article-on-labiotech-watch-ad... | Textduplikat | Read More » |
/category/media-coverage/ | | More Media Coverage |
/2024-04-18-isicem-2024/ | | ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine |
/2024-04-18-isicem-2024/ | Textduplikat | Read More » |
/j-p-morgan-healthcare-confere... | | J.P. Morgan Healthcare Conference & Biotech Showcase 2023 – Meet us in San Francisco |
/j-p-morgan-healthcare-confere... | Textduplikat | Read More » |
/adrenomed-to-attend-upcoming-... | | Adrenomed to attend upcoming industry and investor conferences |
/adrenomed-to-attend-upcoming-... | Textduplikat | Read More » |
/index.php?cat=6 | | More Events |
/wp-content/uploads/2022/06/20... | Neues Fenster | privacy policy |
https://twitter.com/adrenomed | Neues Fenster Extern | Twitter |
https://www.linkedin.com/compa... | Neues Fenster Extern Subdomain | Linkedin |
https://policies.google.com/pr... | Neues Fenster Nofollow Extern Subdomain | Learn more |
https://adrenomed.com/imprint | | Imprint/Impressum |
https://adrenomed.com/legal | | Legal Notice/Datenschutzerklärung | |
/wp-content/uploads/2024/04/Po... | | Expanded Access Policy |
(Nice to have)